Cargando…
Subunit Vaccines Using TLR Triagonist Combination Adjuvants Provide Protection Against Coxiella burnetii While Minimizing Reactogenic Responses
Q fever is caused by the obligate intracellular bacterium, Coxiella burnetii, a designated potential agent of bioterrorism because of its route of transmission, resistance to disinfectants, and low infectious dose. The only vaccine licensed for human use is Q-VAX(®) (Seqirus, licensed in Australia),...
Autores principales: | Fratzke, Alycia P., Jan, Sharon, Felgner, Jiin, Liang, Li, Nakajima, Rie, Jasinskas, Algis, Manna, Saikat, Nihesh, Fnu N., Maiti, Sampa, Albin, Tyler J., Esser-Kahn, Aaron P., Davies, D. Huw, Samuel, James E., Felgner, Philip L., Gregory, Anthony E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010241/ https://www.ncbi.nlm.nih.gov/pubmed/33815413 http://dx.doi.org/10.3389/fimmu.2021.653092 |
Ejemplares similares
-
Multivalent vaccines demonstrate immunogenicity and protect against Coxiella burnetii aerosol challenge
por: Jan, Sharon, et al.
Publicado: (2023) -
Linked Toll-Like Receptor Triagonists Stimulate Distinct,
Combination-Dependent Innate Immune Responses
por: Albin, Tyler J., et al.
Publicado: (2019) -
Engineering
Protein Nanoparticles Functionalized with
an Immunodominant Coxiella burnetii Antigen to Generate
a Q Fever Vaccine
por: Ramirez, Aaron, et al.
Publicado: (2023) -
Contributions of lipopolysaccharide and the type IVB secretion system to Coxiella burnetii vaccine efficacy and reactogenicity
por: Long, Carrie M., et al.
Publicado: (2021) -
Coxiella burnetii Whole Cell Vaccine Produces a Th1 Delayed-Type Hypersensitivity Response in a Novel Sensitized Mouse Model
por: Fratzke, Alycia P., et al.
Publicado: (2021)